Prescription errors are often associated with a pharmacist grabbing the wrong bottle or misreading a dosage. However, some mistakes begin far earlier at the manufacturing stage. A recent nationwide recall involving nearly 40 generic medications is a critical reminder that pharmacy errors can originate in the production process, with consequences for patients across Maryland and beyond.
The U.S. Food and Drug Administration (FDA) recently announced a sweeping recall of medications manufactured by Glenmark Pharmaceuticals. The recall includes common treatments for high blood pressure, seizures, cholesterol, diabetes, and other chronic conditions. These drugs were sold throughout the United States, many through local pharmacies, with some reaching consumers through online retailers like Amazon and Walmart.
Why the Glenmark Medications Were Recalled
The FDA labeled this as a Class II recall, which means the medications pose a risk of temporary or medically reversible health issues. The agency did not specify whether any serious injuries had occurred as a result of these drugs. However, the underlying cause of the recall points to serious lapses in manufacturing standards.